Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib
Clinical trial NCT02489500 · TERMINATED
Trial details
- NCT number
- NCT02489500
- Sponsor
- Boston Medical Center
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-04-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.